Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06292936 · ClinicalTrials.gov registry record · NA

RemI for Post-Bariatric Surgery Weight Regain

A NA study of Obesity and Bariatric Surgery Candidate, sponsored by Temple University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT06292936: Recruiting NA study of Obesity and Bariatric Surgery Candidate, sponsored by Temple University.

NCT06292936 is a NA study of Obesity and Bariatric Surgery Candidate that is actively recruiting participants, run by Temple University. The registered enrollment target is 200 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06292936, a NA study of Obesity and Bariatric Surgery Candidate, is actively recruiting participants, sponsored by Temple University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to test the effectiveness of remotely-delivered interventions (utilizing acceptance-based behavioral treatment skills (ABTi)) amongst bariatric surgery populations who are experiencing weight regain postoperatively (\> 5% from their lowest postoperative weight and after postoperative Month 6). Investigators aim to evaluate ABTi's efficacy for reversing weight regain and its effect on targeted weight control behaviors and weight-related comorbidities by comparing participants randomly assigned ABTi (n = 100) to those assigned to a Control group that also receives brief phone calls but that focus on reiterating instruction on the dietary and behavioral changes required of surgery and initially taught preoperatively (C, n = 100). The main research aims are: 1. To compare changes in body weight over 12 months in 200 bariatric patients who have regained \> 5% of their weight and are randomly assigned to ABTi or Control. 2. To compare changes in eating behaviors (i.e., caloric intake, frequency of maladaptive eating behaviors), physical activity, and weight-related comorbidities (i.e., biomarkers of diabetes, hypertension) over 12 months in the two groups. 3. Exploratory - To test ABTi's theoretical mechanisms of action, including a) effects of theory-based active ingredients (i.e., acceptance, defusion, values clarity, mindfulness) on weight outcomes and b) changes in impact of internal states (i.e., hunger, cravings) on eating behavior.

Primary Outcome

Weight will be measured with a digital scale with participants dressed in light clothes and without shoes. Percent weight loss will be calculated from participants' current weight (at each assessment point) as compared to their baseline weight. Weight will be measured in lbs.

Interventions

  • BEHAVIORAL Acceptance-Based Behavioral Intervention

Study Locations (2)

Illinois

  • Rush University - Chicago

Pennsylvania

  • Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-04-15
Est. Completion 2028-05-31
Phase NA
Temple University

163 total trials

What NCT06292936 shows while recruiting

NCT06292936 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (76% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Acceptance-Based Behavioral Intervention is the first listed.

NCT06292936 reports a single indexed study location in Illinois, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06292936 about?

NCT06292936 is a clinical study titled "RemI for Post-Bariatric Surgery Weight Regain". The goal of this clinical trial is to test the effectiveness of remotely-delivered interventions (utilizing acceptance-based behavioral treatment skills (ABTi)) amongst bariatric surgery populations who are experiencing weight regain postoperatively (\> 5% from their lowest postoperative weight and ...

What is the current status of trial NCT06292936?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-04-15. Estimated completion is 2028-05-31.

What conditions does trial NCT06292936 study?

This clinical trial studies the following conditions: Obesity, Bariatric Surgery Candidate.

What interventions are being tested in trial NCT06292936?

The interventions under investigation include: Acceptance-Based Behavioral Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06292936?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06292936 being conducted?

This trial has 2 study locations across Illinois, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06292936's enrollment target sits among peer trials

200 315th of 1053 higher than 732 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06292936, the US trial registry maintained by the National Library of Medicine. NCT06292936 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.